SMTL ID : 6vwc.2 (1 other biounit)

Crystal structure of Bcl-xL in complex with tetrahydroisoquinoline-pyridine based inhibitors

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.60 Å

Oligo State

monomer

Ligands

1 x RQ7: 6-{8-[(1,3-benzothiazol-2-yl)carbamoyl]-3,4-dihydroisoquinolin-2(1H)-yl}-3-{1-[(pyridin-4-yl)methyl]-1H-pyrazol-4-yl}pyridine-2-carboxylic acid(Non-covalent)

RQ7.1: 21 residues within 4Å: Chain A: A.43, F.47, Y.51, R.52, F.55, S.56, D.57, L.58, T.59, E.79, L.80, R.82, N.86, G.88, R.89, V.91, A.92, S.95, F.96, A.99, Y.145 20 PLIP interactions: 20 interactions with chain A Hydrophobic interactions: A:F.47, A:Y.51, A:F.55, A:L.58, A:T.59, A:R.89, A:A.92, A:F.96, A:A.99, A:Y.145 Hydrogen bonds: A:S.56, A:L.58, A:N.86 Water bridges: A:G.88, A:R.89, A:R.89 Salt bridges: A:R.89 pi-Stacking: A:Y.51, A:F.55, A:F.96

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wang, L. et al., Discovery of A-1331852, a First-in-Class, Potent, and Orally-Bioavailable BCL-X L Inhibitor. Acs Med.Chem.Lett. (2020)

Release Date

2020-10-21

Peptides

Bcl-2-like protein 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Bcl-2-like protein 1

Related Entries With Identical Sequence